Hyrimoz(adalimumab-adaz)
Dosage & Administration
Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis (2.1):
Juvenile Idiopathic Arthritis (2.2):
Pediatric Weight 2 Years of Age and Older | Recommended Dosage |
10 kg (22 lbs) to less than 15 kg (33 lbs) | 10 mg every other week |
15 kg (33 lbs) to less than 30 kg (66 lbs) | 20 mg every other week |
30 kg (66 lbs) and greater | 40 mg every other week |
Crohn's Disease (2.3):
Pediatric Weight | Recommended Dosage | |
Days 1 and 15 | ||
17 kg (37 lbs) to less than 40 kg (88 lbs) | Day 1: 80 mg Day 15: 40 mg | 20 mg every other week |
40 kg (88 lbs) and greater | Day 1: 160 mg (single dose or split over two consecutive days) Day 15: 80 mg | 40 mg every other week |
Ulcerative Colitis (2.4):
Plaque Psoriasis or Adult Uveitis :
Hidradenitis Suppurativa :
Get Your Patient on Hyrimoz
See your patient's specific prior authorization requirements including coverage restrictions and step therapies
Or select your Insurance from the list below:
Hyrimoz Prescribing Information
Request Hyrimoz Samples
Learn More
Is my patient eligible for Hyrimoz samples?
- Your rep will communicate with you how to receive samples, when you can receive samples, the amount and more.
How do I find out who my Hyrimoz rep is?
- Not sure who your local Hyrimoz pharma rep is? Reach out to Sandoz Inc and they can help you identify your rep.
Hyrimoz Prior Authorization Resources
Most recent state uniform prior authorization forms
Verified: Oct 24, 2024Arizona - Uniform Prior Authorization Form
Verified: Oct 24, 2024Colorado - Uniform Prior Authorization Form
Verified: Oct 24, 2024Hawaii - Uniform Prior Authorization Form
Verified: Oct 24, 2024Illinois - Uniform Prior Authorization Form
Verified: Oct 24, 2024Indiana - Uniform Prior Authorization Form
Verified: Oct 24, 2024Louisiana - Uniform Prior Authorization Form
Verified: Oct 24, 2024Minnesota - Uniform Prior Authorization Form
Verified: Oct 24, 2024New Hampshire - Uniform Prior Authorization Form
Verified: Oct 24, 2024New Mexico - Uniform Prior Authorization Form
Verified: Oct 24, 2024Oregon - Uniform Prior Authorization Form
Verified: Oct 24, 2024Texas - Uniform Prior Authorization Form
Verified: Oct 05, 2024Washington - Uniform Prior Authorization Form
Verified: Oct 05, 2024Wisconsin - Uniform Prior Authorization Form
Benefits investigation
Reimbursement help (FRM)
Hyrimoz Financial Assistance Options
Copay savings program
Learn More
Overview
- Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
- A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
- Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
- Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
- May never be used with government insurance
How to sign up
- Cards may be downloadable digital cards or hard copies
- Some pharmacos offer debit cards with pre-loaded copay benefit
- Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
- Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
Bridge program
Learn More
Overview
- Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
- Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)
Patient benefit
- 100% free (outside of insurance)
Patient eligibility
- HCP must enroll patient
- May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries
How to sign up
- Typically HCP assisted enrollment (via form)
Hyrimoz PubMed™ News
Hyrimoz Patient Education
Getting started on Hyrimoz
Instructions For Use: Rheumatoid Arthritis (RA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use: Polyarticular Juvenile Idiopathic Arthritis (JIA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use: Psoriatic arthritis (PsA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use: Ankylosing Spondylitis (AS)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use: Hidradenitis Suppurativa (HS)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use: Crohn’s Disease (CD)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use: Ulcerative Colitis (UC)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link
Patient toolkit
Other resources
Hyrimoz FAQs
Hyrimoz is available in 9 dosages, including 100 mg/ml Auto-Injector 0.4 ml, 100 mg/ml Prefilled Syringe 0.4 ml, 100 mg/ml Prefilled Syringe 0.2 ml, 100 mg/ml Auto-Injector 0.8 ml, mixed Pack, mixed Pack, mixed Pack, mixed Pack and 100 mg/ml Prefilled Syringe 0.1 ml
Hyrimoz treats Arthritis, Juvenile, Arthritis, Rheumatoid, Colitis, Ulcerative, Crohn Disease, Spondylitis, Ankylosing, Uveitis, Arthritis, Psoriatic and Hidradenitis Suppurativa
Hyrimoz contains adalimumab which is a Tumor Necrosis Factor Blocker
Hyrimoz is administered as a Injectable or Pack
Hyrimoz mechanism of action is Tumor Necrosis Factor Receptor Blocking Activity
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available